Your session is about to expire
← Back to Search
Oral Milataxel for Mesothelioma (TL139 Trial)
TL139 Trial Summary
This trial is looking at a new chemotherapy drug for people with mesothelioma who haven't responded to other treatments.
TL139 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTL139 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.TL139 Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am not on high doses of steroids (more than 4 mg of dexamethasone or equivalent).Patients must have a way for the doctors to measure their disease.I have only been treated with pemetrexed and cisplatin for my mesothelioma.I haven't had cancer treatment or radiation in the last 30 days and am not on any cancer drugs now.I do not have any major ongoing health issues.I am not pregnant or breastfeeding.I have not had major surgery in the last 14 days.I need medication that changes how my body processes drugs before starting milataxel.My organs are functioning well.I have mesothelioma and was treated with pemetrexed and cisplatin.I have brain metastases but am currently stable.I have recovered from side effects of previous cancer treatments, except for hair loss.I am expected to live at least 12 weeks and can care for myself.I have moderate to severe nerve damage in my hands or feet.I finished treatments with pemetrexed/cisplatin and any radiotherapy affecting less than 25% of my bone marrow over 30 days ago.I am 18 years old or older.I have a condition that affects how my body absorbs medicine.You are allergic to alcohol.I have brain metastases causing symptoms.
- Group 1: A
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has a research program like this ever been done before?
"Presently, only one Milataxel trial is live in 2 cities across 1 nation. Taxolog Inc.'s clinical trial from 2008 was the first to explore this medicine's efficacy; it necessitated 90 participants and concluded its Phase 2 regulatory process. Since then, no new studies have been conducted."
Has the FDA sanctioned Milataxel as an acceptable treatment?
"Milataxel's safety was assessed with a score of 2 since there is evidence to support its security, yet no research has been conducted regarding the drug's efficacy."
What prior investigations have been conducted with regards to Milataxel?
"Currently, only one clinical trial is actively testing Milataxel. This medical study has not yet reached Phase 3 of the process and is mainly conducted in New york City with three other sites involved."
Are there any vacancies available in this research project?
"As per the information posted on clinicaltrials.gov, this study is not presently accepting patients. This trial was originally published in March 2008 and last edited in May of that same year. Although no new participants can join this specific research project at present, there are 153 other trials actively recruiting right now."
How many participants can this clinical trial accommodate?
"At the moment, applications for this trial are not being accepted. Initially posted on March 1st 2008 and most recently updated May 22nd of the same year; if you're looking to participate in other studies, there is a range of 152 mesothelioma trials and one Milataxel research project actively recruiting patients."
Share this study with friends
Copy Link
Messenger